Compare2 funds · 1 pair
Picked · 2YTD
ASCEvsXPHVersus · 5Y · 3.9% held in commonLevel2–2 on 4
Close to theseFee · YTD
Best of the twoNov 4
  • Lowest cost$ a year on $10kXPH 0.35%
  • Most incometrailing 12-month yieldXPH 0.42%
  • Best 5 yearsper yearXPH +8.1%
  • Smallest drop · 1Yworst fall in the past yearASCE −9.1%
Measures won2–2level · of 6 · 5Y
$10,000 · 5Y$14,771XPH
Lowest cost0.35%XPH · $35 on $10k
Most income0.42%XPH · $42 on $10k
Smallest drop−9.1%ASCE · worst fall in 1Y
Held in common3.9%ASCE and XPH

ASCE vs XPH

5Y
ASCE
XPH
Allspring SMID Core ETF · $356MState Street SPDR S&P Pharmaceuticals ETF · $483M
[…]3 years · per year[…] · $19,044+24.0%
[…]5 years · per year[…] · $14,771+8.1%
0.38%Expense ratio$38 · $35 on $10k · lower wins0.35%
0.18%12-mo yield$18 · $42 on $10k0.42%
−9.1%Worst dropSmaller wins−16.5%
19.4%VolatilityLower wins23.7%
2–2Level
$10,000 · 5 yearsOne scale
$10k startXPH $14.8kOct 2021Nov 2026
Shared top holdingsASCE · XPH
3.1%AMRX2.4%
1.5%CORT1.5%
Held in common3.9%
End-of-day Nov 4, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1BXPHState Street SPDR S&P Pharmaceuticals ETFReadDesk0.35%0.42%+1.6%+17.0%+32.1%+24.0%+8.1%−16.5%$483M
2AASCEAllspring SMID Core ETFReadDesk0.38%0.18%+0.9%+23.4%+27.2%newnew−9.1%$356M
End-of-day Nov 4, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

ASCE vs XPH

5Y
Allspring SMID Core
[…]
SPDR S&P Pharmaceuticals
$14,771
MeasureASCEXPH
Fee0.38%0.35%
Cost on $10k a year$38$35
Yield0.18%0.42%
5 years, per year[…]+8.1%
3 years, per year[…]+24.0%
Worst drop · 1Y−9.1%−16.5%
Volatility · 1Y19.4%23.7%
2–2measures won
level
3.9%
holdings shared
Nov 4, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+35.3%
VIGVanguard
+16.4%
Jan 1Nov 4+35.3%+16.4%
+35.3%Year to date+16.4%
2.9%Yield1.4%
$123BAssets$109B
2–0SCHD wins
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+8.5%
JEPIJ.P. Morgan
+8.8%
Jan 1Nov 4+8.5%+8.8%
+8.5%Year to date+8.8%
12.2%Yield7.8%
$42.1BAssets$46.1B
1–1level
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+13.4%
SPYSPDR
+13.3%
Jan 1Nov 4+13.4%+13.3%
+13.4%Year to date+13.3%
1.0%Yield1.0%
$182BAssets$805B
1–0SPYM wins
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

Overlap: ASCE, XPH

Today
3.9%most shared, ASCE and XPH
ASCEXPH
ASCE—3.9%
XPH3.9%—
End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$7most kept, XPH
XPH$42 − $35 = $7
ASCE$18 − $38 = −$20
KeptFee
End-of-day Nov 4, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com